Physician

Seth G. Kates, M.D.

According to 2025 Medicare claims, Seth Kates, M.D. (NPI: 1760473557) practices dermatology in the Cambridge-Newton-Framingham, MA market, with the plurality of this provider's patient population coming from Middlesex, MA. This provider's primary affiliated billing organization is CHELMSFORD DERMATOLOGY, P.C. (NPI: 1669463493; TIN: 043214243) and primary practice location at 01824-2712.

Kates' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,602 traditional Medicare patients, billed 15,726 HCPCS/CPT codes, and received $1,152,822 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 1,142 prescription claims across 639 beneficiaries totaling $168,235 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 174 records totaling $4,155. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $652,063 to $1,152,822. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $101,551 and ending at $168,235. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,561	11,782	$652,063
2016	2,812	11,977	$633,712
2017	2,831	12,620	$677,634
2018	2,909	13,677	$699,494
2019	3,324	21,194	$893,986
2020	3,111	19,866	$884,490
2021	2,768	16,714	$925,752
2022	2,727	13,884	$870,349
2023	2,870	15,041	$837,274
2024	2,602	15,726	$1,152,822

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	470	900	$101,551
2016	507	961	$187,310
2017	460	871	$135,420
2018	497	886	$98,211
2019	477	911	$175,927
2020	482	935	$183,937
2021	549	1,004	$104,475
2022	482	861	$55,158
2023	569	1,056	$89,156
2024	639	1,142	$168,235

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
11102	Biopsy of related skin growth, first growth	464	523	$77
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	1,514	1,997	$67
17000	Destruction of precancer skin growth, 1 growth	909	1,060	$49
99212	Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	589	659	$42
17003	Destruction of precancer skin growth, 2-14 growths	746	4,976	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Dupixent Pen	Dupilumab	19	520	$67,990
Fluorouracil	Fluorouracil	84	2,585	$4,328
Metronidazole	Metronidazole	39	1,725	$2,153
Triamcinolone Acetonide	Triamcinolone Acetonide	262	6,562	$2,087
Clobetasol Propionate	Clobetasol Propionate	38	1,078	$2,042

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	174	$4,155	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Seth G. Kates, M.D.?

Tedicare shows public-source Medicare data for Seth G. Kates, M.D. (NPI 1760473557), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Seth G. Kates, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Seth G. Kates, M.D.?

Seth G. Kates, M.D. is linked to CHELMSFORD DERMATOLOGY, P.C. (billing NPI 1669463493) in the available physician profile data.

Does Seth G. Kates, M.D. have Open Payments data?

Seth G. Kates, M.D. has 174 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.